Natriumbikarbonat Abboxia (Sodium Hydrogen Carbonate)

The sodium bicarbonate in Natriumbikarbonat Abboxia dissociates into bicarbonate ions, which buffer excess hydrogen ions in the blood. This buffering raises systemic pH, counteracting metabolic acidosis, and increases urinary bicarbonate excretion, thereby raising urine pH for therapeutic purposes.

The dosage of Natriumbikarbonat Abboxia is determined by the prescribing clinician based on the patient’s clinical condition, laboratory values, and response to therapy. Dosing regimens are individualized and should follow institutional protocols and the prescriber’s orders.

Safety data for Natriumbikarbonat Abboxia in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by the treating physician.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required), and necessary import documentation.

Natriumbikarbonat Abboxia delivers sodium bicarbonate directly via intravenous infusion, offering rapid correction of acid‑base disturbances. Compared with oral bicarbonate preparations, it provides faster onset, precise dosing, and is suitable for patients unable to tolerate oral intake or requiring immediate pH correction.

The product must be stored at 2‑8 °C, protected from light, and should not be frozen or shaken. Keep the vial in its original packaging until use and discard any solution that appears discolored or contains particles.

Natriumbikarbonat Abboxia is administered intravenously by a qualified healthcare professional. The solution is typically infused slowly, with the rate adjusted according to the patient’s acid‑base status, electrolyte levels, and clinical response, following the prescriber’s instructions.

Serious risks include severe metabolic alkalosis, hypernatremia, cardiac arrhythmias, pulmonary edema, and rare anaphylactic reactions. Continuous monitoring of blood pH, serum electrolytes, and fluid balance is essential to detect and manage these complications promptly.

Patients with known hypersensitivity to sodium bicarbonate or any excipients, uncontrolled hypertension, severe renal impairment, or those at high risk for fluid overload should avoid this product unless a careful risk‑benefit assessment justifies its use.